-
FDA grants accelerated approval to Zykadia
SILVER SPRING, Md. — The Food and Drug Administration on Tuesday granted approval to Zykadia (ceritinib) for patients with a specific type of late-stage (metastatic) non-small cell lung cancer (NSCLC).
The drug — an anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor — blocks proteins that promote the development of cancerous cells and is intended for patients with metastatic ALK-positive NSCLC who were previously treated with crizotinib.
-
Horizon announces new line of snack products
BROOMFIELD, Colo. — Horizon, a national organic dairy brand, on Tuesday announced the launch of a line of new snack products, which include Horizon Snack Crackers, Sandwich Crackers and Snack Grahams. These items are part of the company's journey outside of the dairy case and come on the heels of several Mac & Cheese products in January.